warfarin

Crosby had his first rib removed from each side and was soon able to stop taking the warfarin. He has been symptom-free for four years.

OBJECTIVE: A stereoselective high performance liquid chromatography(HPLC) was established to determine warfarin enantiomers in human plasma.

Warfarin, a coumarin derivative, is widely used as an oral anticoagulant drug in the treatment and prevention of thromboembolic disorders.

Warfarin is one of the most usually prescribed oral anticoagulation.

Use caution with individuals taking warfarin or other blood thinning medications.

Patients undergoing stent-based PCI should be treated with triple therapy consisting of aspirin, clopidogrel, and warfarin.

The hemorrhages were considered anticoagulant-associated if the patient was on warfarin or heparin.

Do not take while on warfarin therapy without medical advice.

Objective To explore the anxiety and depression of patients taking warfarin due to venous thromboembolism(VTE).

The genotype and allelic frequencies were calculated and the individual warfarin maintenance dosage requirements were analyzed.

In summary, warfarin is highly effective in preventing ischemic strokes in White patients with AF at a modestly higher risk of ICH.

Patients on prescription medicine, including warfarin, should consult their doctor before using this product.

Warfarin is the better choice in the anticoagulative treatment of atrial fibrillation.

To compare the thromboembolism effect of Warfarin with Aspirin in preventing non-valvular atrial fibrillation (AF) patients.

Are there any studies evaluating the patients receiving chronic warfarin therapy and regional anesthesia?

Both of these trials directly compare the new drugs to warfarin.

Objective To compare warfarin and aspirin in the prevention of cerebral embolism in permanent atrial fibrillation.

Warfarin has been shown to be ineffective in preventing recurrent noncardioembolic strokes.

In this study we excluded all patients on warfarin and those with either a diagnosis of gastrointestinal haemorrhage or anaemia.

In food production in the workshop, the packing and warfarin, chemical fertilizer, washing powder sacks and bags are on the same line.

In multiple randomized trials, including THA and TKA patients, LMWH has been more effective than warfarin in limiting overall DVT rates.

Warfarin is substantially more efficacious (by approximately 40%) than antiplatelet therapy.

The mechanisms of ciprofloxacin and ofloxacin affecting warfarin's effect were discussed.

Antiplatelet agents are not as effective as warfarin in reducing the risk of thromboembolism in patients with AF.

Patients on warfarin need regular monitoring to ensure they stay in a safe range.

These new anticoagulants will be the alternatives to warfarin for stroke prophylaxis in AF patients.

Many doctors, including me, would advise you to take an anticoagulant such as warfarin indefinitely.

2What drugs alter prothrombin time by interacting with warfarin levels (pharmacokinetics)?

Garlic, taken in high concentrations in pills, could also interfere with warfarin.

But in clinical practice, many patients take aspirin, clopidogrel or warfarin together to prevent blood clots.

Methods The resistance of R. norvegicus against warfarin and bromadiolone was tested with BCR and feeding method.

She recovered, and is on maintenance therapy with warfarin, a blood thinner.

Many acidic drugs (eg, warfarin, salicylic acid) are highly protein-bound and thus have a small apparent volume of distribution.

In general, the risk of major bleeding with warfarin is somewhere around 1%. The risk of recurrent VTE is higher.

In fact the GI bleeding rates based on RE-LY are comparable to the bleeding rates you see with warfarin.

AIM: To explore the effect of Danshen on warfarin via detecting the patients with atrial fibrillation.

Methods Retrospective analysis of the 7 cases oraIIy warfarin induced hemorrhage in clinical situation, treatment foIIow and outcome.

Also examined is the safety of stating in vulnerable groups, such as the elderly, patients who consume excess alcohol or are on warfarin.

Do they have the potential to replace warfarin in anticoagulation therapy for AF?

3What drugs alter prothrombin time, but not by changing warfarin levels (pharmacodynamics)?

Results: In total, 42 patients (8. 1%) used warfarin at the time of stroke onset.

Warfarin is known to interact with a range of drugs and even some foods and drinks, such as cranberry juice.

Monitor INR values of patients on warfarin (desired range 2-3). Note the interaction with amiodarone.

Methods 377 cases of permanent atrial fibrillation were randomly divided into warfarin group(190 cases)and aspirin group(187 cases).

Each year, around 12, 000 warfarin takers have a major bleed, requiring hospital admission, because their INR rate goes up too much.

Ginseng is associated with side effects such as headache and gastrointestinal symptoms, and it too may interfere with warfarin treatment.

Conclusion: Nearly 4 of 10 patients receiing warfarin management care were receiing warfarin and antiplatelet combination therapy.

Warfarin was temporarily suspended in 437 (90%) of the patients before the procedure, and 114 (22%) received periprocedural heparin therapy.

The herb ginseng, for example, is known to reduce the anticoagulant effect of warfarin, used to prevent thrombosis and embolism.

Methods A non-selective feeding trial was conducted using 0. 025% warfarin and 0. 005% bromadiolone baits.

For example, warfarin (an anticoagulant or blood thinner) is a medication that requires very close monitoring to prevent stroke or death.

The minor bleeding events in middle intensity warfarin group was higher than that in low intensity warfarin group (P05).

Results There were 15 cases(8. 20%) of cerebral embolism in warfarin group and 23 cases(12. 30%) of cerebral embolism in aspirin group.

Objective: To study the effect of anticoagulant therapy of Warfarin in patients with no valvular heart disease and atrial fibrillation.

abstract: Objective To study the effect of gliclazide on the pharmacodynamics and pharmacokinetics of warfarin sodium in rats.

abstract: Objective To study the effect of warfarin sodium on the pharmacokinetics of gliclazide in rats.

Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation

The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin

Clinical study of anticoagulation with warfarin in patients with chronic atrial fibrillation

Gastrointestinal hemorrhage associated with warfarin and metronidazole combination

Clinical Study of Warfarin Versus Aspirin for Thromboembolism Prevention in Patients With Nonvalvular Atrial Fibrillation

Clinical study of the warfarin in prevention of thrombo-embolism among patients with valvular atrial fibrillation

Increased risk of hemorrhage resulting from tramadol-warfarin interaction and its management

Clinical Study of Warfarin in Patients after Heart Mechanical Valve Replacements

Determination of Warfarin in Plasma by HPLC and an Investigation of Monitoring Patients after Cardiac Valve Replacement

A clinical study of warfarin and clopidogrel in prevention of ischemic stroke in patients with nonvalvular atrial fibrillation

The clinical study of oral warfarin therapy after mechanical valve implantation

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement

Assessment of security of anticoagulation of warfarin in patients with atrial fibrillation not due to valvular disease

Study of warfarin preventing thrombus embolism in nonvalve disease atrial fibrillation

Comparative study of the effect of warfarin with aspirin on preventing atrial fibrillation from thrombo-embolism

Upper gastrointestinal hemorrhage associated with concomitant use of warfarin, losartan potassium, fenofibrate and allopurinol

Study on mechanism of left atrial appendage thrombi resolution after anticoagulation with warfarin

Safety and Efficacy of Warfarin on Preventing Thromboembolism in Patients with Atrial Fibrillation

Application of Precursor of Prothrombin in Monitoring of Anticoagulation Effect for Warfarin

Pharmacogenomics guide clinical application of warfarin

Assessment of Security of Warfarin in the Treatment of Anticoagulation in Patients with Atrial Fibrillation

Small dosage warfarin anti-thrombin thrombolysis action clinic observation

Novel Anticoagulant May Provide Warfarin Therapy Alternative

Clinical application of warfarin and its monitoring

Short-term warfarin in treatment for obstruction of catheter with terylene cover in long-term hemodialysis

The Secondary preventive effects and safety observation of warfarin for ischemic stroke

The Anticoagulation Effect of Warfarin vs Aspirin after Bio-prosthetic Heart Valve Replacement

Efficacy and safety of warfarin treatment on the patients with acute myocardial infarction

Low-Molecular-Weight Heparin Useful During Warfarin Interruption

Polarography Determination of Warfarin Sodium

Warfarin Optimal Duration Italian Trial in patients with Pulmonary Embolism

Correlation of Warfarin Plasma Concentration With Clotting Index After a Single Administration

Warfarin in the anticoagulative treatment of atrial fibrillation

Clinical Application of Warfarin in Patients with Atrial Fibrillation

Study on the causes of hemorrhage due to oral warfarin therapy in elderly patients

Prothrombotic States in Atrial Fibrillation and Advances in Research of Warfarin Anticoagulation

The Clinical Application of Prothrombin Time While Taking Warfarin Orally

Warfarin or antifibrinolytic therapy with bleeding

Purification and properties of abnormal prothrombin in the plasma of sheep with warfarin

Related factors affecting anticoagulant effect of warfarin

Clinical Effect of Warfarin to Myocardical Ischemia after Percutaneous Coronary Intervention

Warfarin Optimal Duration Italian Trial in patients with Deep Vein Thrombosis

Interaction between amiodarone and warfarin

Research advances in pharmacogenomics of warfarin

Resolution of left atrial thrombus after administration of low-dose Warfarin

Influence of gene polymorphisms on the anti-coagulation effects of warfarin

AFFIRM Trial Reveals Gender Differences in Warfarin Response

Preparation and Quality Control of Warfarin Sodium Granules

An observation of anticoagulant effect of warfarin in the therapy for patients with nonvalvular atrial fibrillation

The Safety of Warfarin in the Treatment of Anticoagulation in 540 Patients With Persistent Atrial Fibrillation

Study on the dissolubilities of warfarin tablets produced by different manufactories

Comparison between warfarin and aspirin on treatment of unstable angina pectoris in elder patients

Nursing care of senile patients with non- valvar atrial fibrillation undergoing warfarin treatment

Effect of warfarin on experimental calcium oxalate stone formation in rats

Experiences of warfarin therapy for 11 senile patients with non-valvular atrial fibrillation

Elderly AF Patients at Hemorrhage Risk Independent of Warfarin Use

Death from cerebral hemorrhage induced by warfarin

Investigation on the Resistance of Rattus norvegicus to Warfarin in changchun'two regions

Interactions of warfarin and its safe use

Warfarin vs Aspirin for Symptomatic Intracranial Disease, WASID

Treatment of black and white dairy cattle poisoning by warfarin

Report of 5 cases on medicines promoting the anticoagulative efficacy of warfarin

Study use of warfarin sodium after mechanical heart valve replacement

Combinative Use of Low Molecular Weight Heparin and Warfarin in Unstable Angina Pectoris